Johanna Kellett

Johanna Kellett has a diverse work experience in the pharmaceutical industry. Johanna is currently the Head of US OTC Research & Development at Haleon since September 2023. Prior to that, they worked at GSK as the US Pain R&D Lead from July 2022 to August 2023. Johanna'sprevious roles at GSK include R&D Leader in various areas, such as Allergy, Skin Health, and Smokers' Health, from 2018 to 2022. Johanna also served as the Director of New Product Development for Allergy and held positions as a Principal Scientist and a Sr. Development Scientist at GSK. Before joining GSK, Johanna worked as a Pharmaceutical Sales Representative and an Analytical Scientist at GSK from 2004 to 2009. Johanna began their career as a Quality Control Scientist at Organon from 1999 to 2004.

Johanna Kellett earned a Bachelor of Science degree in Chemistry from Fairleigh Dickinson University between 1996 and 2000.